Kim et al.’s [37] research employed metastatic colon cancer cell lines CT26 and HCT116, revealing that AST inhibits epithelial-mesenchymal transition (EMT) primarily by up-regulating microRNA (miR)-29a-3p to suppress matrix metalloproteinase (MMP) 2 activity and enhancing miR-200a to inhibit Zinc Finger E-Box Binding Homeobox 1 (ZEB1) expression. Here, ZEB1 is linked to colonic neoplasm.